Figure 6From: Efficacy, safety and tolerability of tofacitinib in patients with an inadequate response to disease modifying anti-rheumatic drugs: a meta-analysis of randomized double-blind controlled studies Mantel-Haenszel odds ratio of patients who discontinued the treatment due to treatment-emergent adverse events. Back to article page